Glossary entry (derived from question below)
English term or phrase:
MMD responders
French translation:
Répondeurs JMM
Added to glossary by
Claire Mendes Real
Sep 29, 2023 13:11
8 mos ago
27 viewers *
English term
Serious and meeting of deadlines guarant
Native in: French 
Works in: English to French, Spanish to French
MMD responders
English to French
Medical
Medical: Pharmaceuticals
Test de produits
Statistically significant findings were demonstrated for all primary and secondary efficacy endpoints (MMD reduction, >50% MMD responders, headache days, acute treatment use, function and QoL endpoints)
I didn't find what is MMD. It is a about a treatment for Preventative Migraine TPP — Product A
For the preventive treatment of adults with episodic migraine
Thank you
I didn't find what is MMD. It is a about a treatment for Preventative Migraine TPP — Product A
For the preventive treatment of adults with episodic migraine
Thank you
Proposed translations
(French)
| 4 +3 | Répondeurs JMM |
Nadia A.
|
Proposed translations
+3
4 mins
Selected
Répondeurs JMM
Monthly migraine days:
https://ihs-headache.org/wp-content/uploads/2021/11/Fan-Chen...
https://ihs-headache.org/wp-content/uploads/2021/11/Fan-Chen...
Note from asker:
| 50 % des répondeurs JMM? il s'agit de personnes souffrant de migraines? |
| Est-ce que "personnes qui suivent un traitement des JMM" convient? |
4 KudoZ points awarded for this answer.
Comment: "Merci"
Reference comments
2 hrs
Reference:
see
https://thejournalofheadacheandpain.biomedcentral.com/articl...
Background
The goal of this observational, open-label, cohort study was to determine whether prophylactic migraine treatment with galcanezumab, a peripherally acting drug, alters the incidence of premonitory symptoms, and/or occurrence of headache after exposure to triggers or aura episodes in treatment-responders (≥ 50% reduction in monthly migraine days [MMD]), super-responders (≥ 70%), non-responders (
Background
The goal of this observational, open-label, cohort study was to determine whether prophylactic migraine treatment with galcanezumab, a peripherally acting drug, alters the incidence of premonitory symptoms, and/or occurrence of headache after exposure to triggers or aura episodes in treatment-responders (≥ 50% reduction in monthly migraine days [MMD]), super-responders (≥ 70%), non-responders (
Something went wrong...